Skip to content

Screener

Eligibility screening

TJ033721 (givastomig) in Subjects with Advanced or Metastatic Solid Tumors

Sponsored by I-Mab Biopharma US LimitedStudy detailsClinicalTrials.gov

11 US sites in CA, CO, IN, MA +6

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.